Glicla-Natrapharm

Main information

  • Trade name:
  • Glicla-Natrapharm 30 mg Modified Release Tablet
  • Dosage:
  • 30 mg
  • Pharmaceutical form:
  • Modified Release Tablet
  • Units in package:
  • Alu-Clear PVDC Blister Pack x 10's (box of 60's); Alu-Clear PVDC Blister Pack x 15's (box of 15's)
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug
  • Manufactured by:
  • Lloyd Laboratores, Inc.

Documents

Localization

  • Available in:
  • Glicla-Natrapharm 30 mg Modified Release Tablet
    Philippines
  • Language:
  • English

Status

  • Source:
  • FDA - Food And Drug Administration - Philippines
  • Authorization number:
  • DR-XY38504
  • Authorization date:
  • 15-09-2020
  • Last update:
  • 06-04-2018